Related Experiment Video
Updated: Aug 11, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic
Guido Eibl1, Dennis Bruemmer, Yuji Okada
1Section of Gastrointestinal Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, 72-231 CHS, Los Angeles, CA 90095-6904, USA.
Abstract:
In some cancers cyclooxygenase (COX) inhibition appears to be anti-mitogenic and anti-angiogenic, but the actions of COX-derived prostaglandins in pancreatic cancer (PaCa) are unknown. In this study COX-2 was detected in three of six PaCa cell lines while COX-1 was identified in all cell lines. COX-2 expression correlated with basal and arachidonic acid (AA) stimulated PGE(2) production. PGE(2) production was inhibited by the COX-2 inhibitor nimesulide. In COX-2 expressing cells, exogenous AA and PGE(2) increased VEGF synthesis via the EP(2) receptor. Whereas PGE(2) stimulated intracellular cAMP formation in COX-2 positive and negative cells, 8-bromo cAMP stimulated VEGF production only in COX-2 expressing cells. Stimulating COX-2 expressing PaCa cell lines with AA enhanced migration of endothelial cells, an effect which was inhibited by a COX-2 inhibitor and EP(2) receptor antagonist. These data identify a subset of human PaCa cell lines that express functional COX-2 enzyme. PGE(2) generated by specific COX-2 activity increases VEGF secretion in human PaCa cells through an autocrine mechanism.
Insights
Cyclooxygenase-2 (COX-2) in pancreatic cancer cells produces prostaglandin E2 (PGE2). This PGE2 stimulates vascular endothelial growth factor (VEGF) secretion, promoting cancer cell growth and migration.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cyclooxygenase (COX) inhibition shows anti-cancer effects in some tumors.
- The role of COX-derived prostaglandins in pancreatic cancer (PaCa) remains unclear.
Purpose of the Study:
- To investigate the expression and function of COX enzymes in pancreatic cancer cell lines.
- To determine the effect of prostaglandin E2 (PGE2) on vascular endothelial growth factor (VEGF) synthesis and endothelial cell migration in PaCa.
Main Methods:
- Detection of COX-1 and COX-2 expression in PaCa cell lines.
- Measurement of PGE2 production stimulated by arachidonic acid (AA).
- Assessment of VEGF synthesis and endothelial cell migration in response to AA, PGE2, and cAMP analogs.
Main Results:
- COX-2 was detected in a subset of PaCa cell lines, correlating with PGE2 production.
- PGE2, generated via COX-2 activity, increased VEGF synthesis through the EP2 receptor in a COX-2 dependent manner.
- AA stimulation of COX-2 expressing PaCa cells enhanced endothelial cell migration, an effect blocked by COX-2 inhibition.
Conclusions:
- A subset of human pancreatic cancer cell lines express functional COX-2.
- COX-2-derived PGE2 plays a role in increasing VEGF secretion via an autocrine mechanism.
- This suggests a potential therapeutic target for pancreatic cancer treatment.
Related Concept Videos
Cell Specific Gene Expression
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease II: Pathophysiology

